Placental peptides regulating islet adaptation to pregnancy: clinical potential in gestational diabetes mellitus
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
HighlightsFailure of maternal &bgr;‐cells to adequately adapt to the demands of pregnancy is the main contributing factor in onset of GDM.Of its many roles, the placenta is an essential endocrine organ, maintaining pregnancy and regulating maternal adaptation.Several placental peptide hormones (e.g. placental lactogen, adipokines, HGF) regulate islet changes in pregnancy in rodents.The &bgr;‐cell adaptations during pregnancy in humans is less understood but is a major area of ongoing research.Understanding role of placental signals in &bgr;‐cell response is key for early identification of GDM risk and potential therapeutic interventions. &NA; Pregnancy involves a progressive increase in insulin resistance and the &bgr;‐cells must adapt to compensate and prevent gestational diabetes (GDM). In this review we discuss the evidence for placental peptides, including placental lactogen, hepatocyte growth factor, adiponectin and leptin, playing a role in the islet adaptation to pregnancy. The difficulties of translating data from rodent models into human pregnancy are covered and we summarise studies investigating associations between serum placental peptides and GDM risk. In conclusion, current data support important roles for placental peptides interacting to support &bgr;‐cells during pregnancy, however mechanisms involved in humans are unclear. Further work in humans is required, but placental peptides have clinical potential from both a diagnostic and therapeutic perspective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serotonin regulates pancreatic beta cell mass during pregnancy
Kim, H., Toyofuku, Y., Lynn, F. C., Chak, E., Uchida, T., Mizukami, H., Fujitani, Y., Kawamori, R., Miyatsuka, T., Kosaka, Y., et al. (2010) · Nature Medicine · doi:10.1038/nm.2173 · Cited by 586 · cited 1×
“The lactogenic hormones also stimulate b-cell production of serotonin during pregnancy [13], which appears to play a critical local role in regulating b-cell mass [14], mediating the effects of prolactin (Table 1).”
BackgroundSorenson, R., & Brelje, T. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979040 · Cited by 531
Parsons, J. A. (1992) · Endocrinology · doi:10.1210/en.130.3.1459 · Cited by 476
Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy
Butler, A. E., Cao-Minh, L., Galasso, R., Rizza, R. A., Corradin, A., Cobelli, C., & Butler, P. C. (2010) · Diabetologia · doi:10.1007/s00125-010-1809-6 · Cited by 435 · cited 1×
“The limited data suggests b-cell proliferation does not increase in human pregnancy, as assessed by Ki67 staining, and neogenesis is more important in humans [67].”
BackgroundBenner, C., van der Meulen, T., Cacéres, E., Tigyi, K., Donaldson, C. J., & Huising, M. O. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-620 · Cited by 302 · cited 1×
“Human PLs are derived from duplications of the hGH gene, whilst rodent PLs are evolved from the prolactin gene [15], and the Prlr gene is significantly enriched in mouse b-cells compared to human, perhaps indicating a lesser role in human b-cell adaptation [16,17].”
BackgroundKulkarni, R. N., Wang, Z. L., Wang, R. M., Hurley, J. D., Smith, D. M., Ghatei, M. A., Withers, D. J., Gardiner, J. V., Bailey, C. J., & Bloom, S. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119818 · Cited by 296 · cited 1×
“Leptin reduces glucose-induced insulin secretion in isolated mouse islets [45,46] when administered to mice in vivo [47] and in isolated human islets [47,48].”
BackgroundHuang, C., Snider, F., & Cross, J. C. (2009) · Endocrinology · doi:10.1210/en.2008-1003 · Cited by 275
Chen, J., Tan, B., Karteris, E., Zervou, S., Digby, J., Hillhouse, E. W., Vatish, M., & Randeva, H. S. (2006) · Diabetologia · doi:10.1007/s00125-006-0194-7 · Cited by 272 · cited 1×
“serum adiponectin in GDM is at least partly due to low placental, as opposed to adipocyte, secretion [42].”
BackgroundGestational Diabetes Mellitus From Inactivation of Prolactin Receptor and MafB in Islet β-Cells
Banerjee, R. R., Cyphert, H. A., Walker, E. M., Chakravarthy, H., Peiris, H., Gu, X., Liu, Y., Conrad, E., Goodrich, L., Stein, R. W., et al. (2016) · Diabetes · doi:10.2337/db15-1527 · Cited by 131
Retnakaran, R., Ye, C., Kramer, C. K., Connelly, P. W., Hanley, A. J., Sermer, M., & Zinman, B. (2016) · Diabetes Care · doi:10.2337/dc16-0043 · Cited by 64
Pérez-Pérez, A., Maymó, J., Gambino, Y., Guadix, P., Dueñas, J., Varone, C., & Sánchez-Margalet, V. (2013) · Hormone and Metabolic Research · doi:10.1055/s-0032-1333276 · Cited by 57
Cited by
Developmental origins of metabolic diseases
Hoffman, D. J., Powell, T. L., Barrett, E. S., & Hardy, D. B. (2021) · Physiological Reviews · doi:10.1152/physrev.00002.2020 · Cited by 466
Pathophysiology from preconception, during pregnancy, and beyond.
Hivert, M.-F., Backman, H., Benhalima, K., Catalano, P., Desoye, G., Immanuel, J., McKinlay, C. J. D., Meek, C. L., Nolan, C. J., Ram, U., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00827-4 · Cited by 186
Stern, C., Schwarz, S., Moser, G., Cvitic, S., Jantscher-Krenn, E., Gauster, M., & Hiden, U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312722 · Cited by 114
“While adiponectin and leptin are synthesized mainly by adipose tissue, both are also reported to be released from the placenta and secreted into maternal circulation [3,83,84].”
BackgroundInfluentialHigh Folate, Perturbed One-Carbon Metabolism and Gestational Diabetes Mellitus
Williamson, J. M., Arthurs, A. L., Smith, M. D., Roberts, C. T., & Jankovic-Karasoulos, T. (2022) · Nutrients · doi:10.3390/nu14193930 · Cited by 56
Metadata
- Authors
- Simpson, S., Smith, L., & Bowe, J.
- Venue
- Current Opinion in Pharmacology
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 43
- Pages
- 59-65
- ISSN
- 1471-4892 (ISSN-L)
- OpenAlex
- W2892261498
- Cited by
- 45
- References
- 11
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.